AANEM Connect
Join this vibrant community of professionals eager to exchange ideas, share resources, and engage in meaningful discussions. Use this platform as a sounding board to seek advice for navigating challenging cases or career decisions, and receive expert guidance from generous peers who want to help you succeed.
Phenol Medication Denials
Our practice is having difficulty getting phenol covered for spasticity management. Specifically our North Carolina Medicaid contact is saying
"I cannot find Phenol in any reference. Do you have proof it is a drug? Our policy would not allow us to cover any product other than an FDA approved drug. Can proof be provided that I can pass along to see if we can get this drug added to the coverage list?"
Any thoughts on a best response to this? I would think that Medicaid would "want" phenol used for spasticity rather than botox since it is cheaper and lasts longer.
Thanks!
John Norbury
In order to comment on posts and view posts in their entirety, please login with your AANEM member account information.
I enjoy participating in the AANEM Connect Forum for a number of reasons. There are very fundamental questions posed on a frequent basis that cause me to pause and ask myself, ‘Why didn’t I think of that?’ Also, I continue to learn new things when others contribute their thoughts and experiences. Connect is an excellent opportunity for members to interact and to address any topic, including those that may not be discussed at an annual meeting or journal article.
Daniel Dumitru, MD, PhD